Minimal impact of ivermectin on immune response and transcriptional profiles in naïve adults with mild COVID-19
Marta Ribes, Cèlia Torres, Mar Canyelles, Rocío Rubio, Marta Vidal, Luís Izquierdo, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernández‐Montero, Carlota Jordán-Iborra, Francisco Carmona-Torre, José Ramón Yuste, José Luís del Pozo, Gabriel Reina, Belén Sádaba, , Gemma Moncunill
This study evaluates the immunomodulatory effects of ivermectin in mild COVID-19 patients and finds no significant immune response changes, consistent with clinical trial results.
bioRxiv · Mar 31, 2025 · PreprintImmunology